
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study
Author(s) -
Cooper V,
Horne R,
Ewan J
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p42
Subject(s) - medicine , human immunodeficiency virus (hiv) , pharmacology , family medicine
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK